From the ODAC Poster Hall | Imaging and Diagnostic Discordance in Inpatient Dermatology
Imaging is a mainstay of inpatient diagnostics. X-ray, MRI and CT scans are used to diagnose everything from broken bones to cancer. Yet these same imaging modalities are often ordered by hospitalists to diagnose dermatologic conditions even though the findings aren’t typically helpful in making an accurate diagnosis. These unnecessary tests are costly, delay an accurate diagnosis, and can add e …
Imaging is a mainstay of inpatient diagnostics. X-ray, MRI and CT scans are used to diagnose everything from broken bones to cancer. Yet these same imaging modalities are often ordered by hospitalists to diagnose dermatologic conditions even though the findings aren’t typically helpful in making an accurate diagnosis. These unnecessary tests are costly, delay an accurate diagnosis, and can add e … 
Microtoxin or microbotox is a novel approach in aesthetics where microdosed botulinum toxin is placed into the dermis. Unlike traditional neuromodulators that target skeletal muscle, microtoxin acts within the dermis, impacting sebaceous and eccrine glands, arrector pili contraction, fibroblast signaling, and neurovascular pathways. The result is enhanced skin quality without impaired facial muscl … 
At the 2026 ODAC Dermatology Conference in Orlando, Florida, Dr. Olayemi Sokumbi, MD delivered a masterclass on clinicopathologic correlation. A board-certified dermatologist and dermatopathologist widely recognized for her expertise in complex medical dermatology, Dr. Sokumbi showcased her special interest in diagnostic dilemmas in her talk. She emphasized the critical role of clinicopathologic c … 
At the 2026 ODAC Dermatology Conference in Orlando, Dr. Misty Eleryan, Clinical Assistant Professor of Dermatology at George Washington University and Director of Mohs Surgery and Cutaneous Oncology at Chosen Dermatology in Los Angeles, California, presented her talk “Sun Protection 2.0: Advances in UV Filters, Blue Light Defense, & Beyond” which detailed new developments in our understand … 
New research is supporting the use of two innovative products for acne: a triple combination therapy and the first new molecule for acne in 40 years. In this Next Steps in Derm interview, in partnership with the ODAC Dermatology Conference, Brooklyn, N.Y., dermatologist Dr. Hilary Baldwin outlines the latest acne studies and how these new treatments are helping dermatology clinicians address the f …